Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of 68Ga-HBED-CC-PSMA PET/CT in Prostate Cancer

NCT03001869 is registered in ClinicalTrials.gov with Sir Mortimer B. Davis - Jewish General Hospital as lead sponsor.

NCT NCT03001869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03001869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of 68Ga-HBED-CC-PSMA PET/CT in Prostate Cancer
Lead sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2017
Completion date
July 1, 2023
Enrollment
540 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer